Phillip J Mease (Philip Mease, Phillip Mease, Philip J Mease)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 126

Top Venues

The Journal of rheumatology

RMD open

Annals of the rheumatic diseases

The Journal of rheumatology. Supplement

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Phillip J Mease, Peter Nash, Suzanne M Dolwick Grieb, Vinod Chandran
Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis. The Journal of rheumatology (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
Dennis McGonagle, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, May Shawi, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Stephen Xu, Christopher T Ritchlin, Proton Rahman, Phillip J Mease
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. ACR open rheumatology (2023)
Alice B Gottlieb, Iain B McInnes, Proton Rahman, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Frederic Lavie, Phillip J Mease
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis. RMD open 9 (1) (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
Alice B Gottlieb, Iain B McInnes, Proton Rahman, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Frederic Lavie, Phillip J Mease
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis. RMD open 9 (1) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Phillip J Mease, Philip S Helliwell, Diamant Thaҫi, Natalie J Shiff, Iris Lin, Soumya D Chakravarty, Michael S Kelleman, Rhiannon Dodge, Robert R McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph Frank Merola
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. Rheumatology and therapy (2023)
Phillip J Mease, Alice B Gottlieb, Philip S Helliwell, Iain B McInnes, Soumya D Chakravarty, Emmanouil Rampakakis, Alexa P Kollmeier, Xie L Xu, May Shawi, Frederic Lavie, Kishimoto Mitsumasa, Proton Rahman
Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment. Clinical rheumatology (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Frank Behrens, Maarten P T de Wit, Oliver M FitzGerald, Dafna D Gladman, Phillip J Mease, Denis O'Sullivan, Stephen R Pennington, Larissa Valor-Méndez, Vinod Chandran, Kurt de Vlam
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of rheumatology (2023)
Ana Margarida Pinto, Rinie Geenen, Tor D Wager, Winfried Häuser, Eva Kosek, Jacob N Ablin, Kirstine Amris, Jaime C Branco, Dan Buskila, João Castelhano, Miguel Castelo-Branco, Leslie J Crofford, Mary-Ann Fitzcharles, Marina López-Solà, Mariana Luís, Tiago Reis Marques, Phillip J Mease, Filipe Palavra, Jamie L Rhudy, Lucina Q Uddin, Paula Castilho, Johannes W G Jacobs, José António Pereira Da Silva
Reply to: Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia. Nature reviews. Rheumatology (2023)
Proton Rahman, Wolf-Henning Boehncke, Phillip J Mease, Alice B Gottlieb, Iain B McInnes, May Shawi, Yanli Wang, Shihong Sheng, Alexa P Kollmeier, Elke Theander, Jenny Yu, Evan Leibowitz, A Marilise Marrache, Laura C Coates
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis. The Journal of rheumatology (2023)
Leonard H Calabrese, Phillip J Mease
Improving the nosology of Long COVID: it is not so simple. Annals of the rheumatic diseases (2023)
Phillip J Mease, Dafna D Gladman, Denis Poddubnyy, Soumya D Chakravarty, May Shawi, Alexa P Kollmeier, Xie L Xu, Stephen Xu, Atul Deodhar, Xenofon Baraliakos
Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study. Rheumatology and therapy (2023)
Phillip J Mease, Philip S Helliwell, Paula Silwinska-Stanczyk, Malgorzata Miakisz, Andrew Ostor, Elena Peeva, Michael S Vincent, Qiankun Sun, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean S Beebe, David A Martin
Efficacy and Safety of Tyrosine Kinase 2/Janus Kinase 1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Lihi Eder, Dafna D Gladman, Phillip J Mease, Remy A Pollock, Rayana Luna, Sibel Zehra Aydın, Alexis Ogdie, Ari Polachek, David Gruben, Mary Jane Cadatal, Cassandra Kinch, Vibeke Strand
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension. RMD open 9 (1) (2023)
Ying Ying Leung, William Tillett, Maarten de Wit, Ana Maria Orbai, Laura C Coates, Oliver M FitzGerald, Philip S Helliwell, Vibeke Strand, Phillip J Mease, Niti Goel, Robin Christensen, Joseph Frank Merola, Christine A Lindsay, Philip S Helliwell, Laure Gossec, Dafna D Gladman
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group. The Journal of rheumatology (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
Christopher T Ritchlin, Laura C Coates, Iain B McInnes, Phillip J Mease, Joseph F Merola, Yoshiya Tanaka, Akihiko Asahina, Laure Gossec, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Robert B M Landewé
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study. Annals of the rheumatic diseases (2023)
Murat Torğutalp, Dafna D Gladman, Oliver M FitzGerald, Phillip J Mease, Denis Poddubnyy
Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis. The Journal of rheumatology (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Adewale O Adebajo, Gizem Ayan, Kristina Callis Duffin, Vinod Chandran, Laura C Coates, Maria Antonietta D'Agostino, Kurt de Vlam, Atul A Deodhar, Lihi Eder, Amit Garg, Dafna D Gladman, Niti Goel, Alice B Gottlieb, M Elaine Husni, Arnon M Katz, Arthur Kavanaugh, Ennio Lubrano, Phillip J Mease, Joseph Frank Merola, Peter Nash, Philip S Helliwell, Stephen R Pennington, Lourdes Maria Perez-Chada, Fabian Proft, Cheryl F Rosen, Laura Savage, Cláudia Goldenstein-Schainberg, Stefan Siebert, Enrique Roberto Soriano, Ingrid Steinkoenig, William Tillett, April W Armstrong, Oliver M FitzGerald
Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of rheumatology (2023)
Ana Margarida Pinto, Rinie Geenen, Tor D Wager, Mark A Lumley, Winfried Häuser, Eva Kosek, Jacob N Ablin, Kirstine Amris, Jaime C Branco, Dan Buskila, João Castelhano, Miguel Castelo-Branco, Leslie J Crofford, Mary-Ann Fitzcharles, Marina López-Solà, Mariana Luís, Tiago Reis Marques, Phillip J Mease, Filipe Palavra, Jamie L Rhudy, Lucina Q Uddin, Paula Castilho, Johannes W G Jacobs, José António Pereira Da Silva
Reply to 'Imbalance of threat and soothing systems in fibromyalgia: rephrasing an established mechanistic model?' Nature reviews. Rheumatology (2023)
Karamarie Fecho, Chris Bizon, Tursynay Issabekova, Sierra A T Moxon, Anne E Thessen, Shervin Abdollahi, Sergio E Baranzini, Basazin Belhu, William E Byrd, Lawrence Chung, Andrew B Crouse, Marc P Duby, Stephen S Ferguson, Aleksandra Foksinska, Laura Forero, Jennifer Friedman, Vicki Gardner, Gwênlyn Glusman, Jennifer J Hadlock, Kristina Hanspers, Eugene Hinderer, Charlotte A Hobbs, Gregory Hyde, Sui Huang, David Koslicki, Phillip J Mease, Sandrine Muller, Christopher John Mungall, Stephen A Ramsey, Jared C Roach, Irit R Rubin, Shepherd H Schurman, Anath Shalev, Brett Smith, Karthik Soman, Sarah Stemann, Andrew I Su, Casey Ta, Paul B Watkins, Mark D Williams, Chunlei Wu, Colleen H Xu, null null
An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges. Journal of clinical and translational science 7 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Phillip J Mease, Jacqueline O'Brien, Nicole Middaugh, Gregory Kricorian, Scott Stryker, David H Collier, Alexis Ogdie
Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. ACR open rheumatology (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Laura C Coates, Phillip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD open 9 (2) (2023)
Dafna D Gladman, Phillip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul A Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Xenofon Baraliakos, Effie Pournara, Laure Gossec, Phillip J Mease, Roisin White, Eamonn O'Brien, Barbara Schulz, Helena Marzo-Ortega, Laura C Coates
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial. RMD open 8 (2) (2022)
Laura C Coates, Enrique R Soriano, Nadia Corp, Heidi Bertheussen, Kristina Callis Duffin, Cristiano B Campanholo, Jeffrey Chau, Lihi Eder, Daniel G Fernández-Ávila, Oliver M FitzGerald, Amit Garg, Dafna D Gladman, Niti Goel, Philip S Helliwell, M Elaine Husni, Deepak R Jadon, Arnon Katz, Dhruvkumar Laheru, John Latella, Ying Ying Leung, Christine A Lindsay, Ennio Lubrano, Luis Daniel Mazzuoccolo, Phillip J Mease, Denis O'Sullivan, Alexis Ogdie, Wendy Olsder, Penelope Esther Palominos, Lori Schick, Ingrid Steinkoenig, Maarten P T de Wit, D A van der Windt, Arthur Kavanaugh, null null
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature reviews. Rheumatology 18 (8) (2022)
Ana Margarida Pinto, Rinie Geenen, Tor D Wager, Mark A Lumley, Winfried Häuser, Eva Kosek, Jacob N Ablin, Kirstine Amris, Jaime C Branco, Dan Buskila, Joao Castelhano, Miguel Castelo-Branco, Leslie J Crofford, Mary-Ann Fitzcharles, Marina López-Solà, Mariana Luís, Tiago Reis Marques, Phillip J Mease, Filipe Palavra, Jamie L Rhudy, Lucina Q Uddin, Paula Castilho, Johannes W G Jacobs, José António Pereira Da Silva
Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia. Nature reviews. Rheumatology (2022)
James C Waddington, Orla Coleman, Phillip J Mease, Vinod Chandran, Denis O'Sullivan, Oliver M FitzGerald, Stephen R Pennington
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA Projects. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Carmel Stober, Iain B McInnes, Soumya Raychaudhuri, Phillip J Mease, Stephen R Pennington, Jose U Scher, Vinod Chandran, April W Armstrong, Maarten P T de Wit, Alberto Cauli, Deepak R Jadon, Thorvardur Jon Love, Philip S Helliwell, Denis O'Sullivan, Leonieke J J van Mens, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Phillip J Mease, Soumya D Chakravarty, Robert R McLean, Taylor Blachley, Toana Kawashima, Iris Lin, Arthur Kavanaugh, Alexis Ogdie
Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. ACR open rheumatology 4 (5) (2022)
Iain B McInnes, Andrew J K Ostor, Phillip J Mease, William Tillett, Xenofon Baraliakos, Kurt de Vlam, Louis Bessette, Ralph Lippe, Anna Maniccia, Dai Feng, Tianming Gao, Patrick Zueger, Christopher Saffore, Koji Kato, In-Ho Song, Atul Deodhar
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials. RMD open 8 (1) (2022)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, John Tesser, Elena Schiopu, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, May Shawi, Yusang Jiang, Shihong Sheng, Yanli Wang, Stephen Xu, Joseph F Merola, Iain B McInnes, Atul Deodhar
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies. RMD open 8 (1) (2022)
Phillip J Mease, Atul A Deodhar
Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review. BMC musculoskeletal disorders 23 (1) (2022)
Phillip J Mease, Atul A Deodhar, Désirée Mfm van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Annals of the rheumatic diseases 81 (6) (2022)
Phillip J Mease, Taylor Blachley, Blessing Dube, Robert R McLean, Nina Kim, Peter Hur, Philip S Helliwell
Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. The Journal of rheumatology 49 (7) (2022)
Phillip J Mease, Herbert Kellner, Akimichi Morita, Alan J Kivitz, Stella Aslanyan, Steven J Padula, Andrew S Topp, Ann Eldred, Frank Behrens, Kim A Papp
Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial. Rheumatology and therapy 9 (5) (2022)
Phillip J Mease, Arthur Kavanaugh, Philip S Helliwell, Alvin F Wells, Martin Bergman, Dafna D Gladman, Sven Richter, Lichen Teng, Shauna Jardon, Josef S Smolen
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis. The Journal of rheumatology 49 (7) (2022)
Philip S Helliwell, Phillip J Mease, Arthur Kavanaugh, Laura C Coates, Philip S Helliwell, Atul Deodhar, Vibeke Strand, Gregory Kricorian, Lyrica X H Liu, David Collier, Dafna D Gladman
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial. RMD open 8 (2) (2022)
Anna S Antony, Richard Holland, Ashish J Mathew, Maria Antonietta D'Agostino, Walter P Maksymowych, Phillip J Mease, Niti Goel, Philip S Helliwell, Laura C Coates, Vibeke Strand, Robin Christensen, Dafna D Gladman, Ana Maria Orbai, Ying Ying Leung, William Tillett
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Phillip J Mease, Dafna D Gladman, Joseph Frank Merola, Atul Deodhar, Philip S Helliwell, David H Collier, Lyrica Liu, Arthur Kavanaugh
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial. The Journal of rheumatology 49 (8) (2022)
Laura C Coates, Josef S Smolen, Phillip J Mease, M Elaine Husni, Joseph F Merola, Eric Lespessailles, Kishimoto Mitsumasa, Lisa Macpherson, Andrew J Bradley, Rebecca Bolce, Philip S Helliwell
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis. RMD open 8 (2) (2022)
Phillip J Mease, Kevin L Winthrop, Wendy Olsder, Jeffrey R Curtis
COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Philip S Helliwell, Christine A Lindsay, Phillip J Mease, Kristina Callis Duffin, Cheryl F Rosen, Stefan Siebert
Challenges in the Diagnosis and Assessment of Psoriatic Arthritis. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Phillip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewé, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Elenore Judy B Uy, Pedro M Machado, Walter Maksymowych, Anna Moltó, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Josef S Smolen, In-Ho Song, Salima van Weely, Désirée Mfm van der Heijde
Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Annals of the rheumatic diseases (2022)
April W Armstrong, Rasika M Reddy, Oliver M FitzGerald, Kristina Callis Duffin, Philip S Helliwell, Phillip J Mease, Arthur Kavanaugh, Joseph Frank Merola, William Tillett, Maarten de Wit
2021 GRAPPA Meet the Experts Session: A Summary of Presentations. The Journal of rheumatology 49 (6 Suppl 1) (2022)
Phillip J Mease, Akihiko Asahina, Dafna D Gladman, Yoshiya Tanaka, William Tillett, Barbara Ink, Deepak Assudani, Christine de la Loge, Jason Coarse, Jason Eells, Laure Gossec
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE. Rheumatology (Oxford, England) (2022)
Lihi Eder, Ashish J Mathew, Philippe Carron, Heidi Bertheussen, Juan D Cañete, May Azem, Andrea Delle Sedie, Carlo Salvarani, Roberto Ranza, Ashley Elliott, Anthony Turkiewicz, Ricardo Acayaba de Toledo, Hulya Bukulmez, Maria S Stoenoiu, Arthur M Mandelin, Michaela Köhm, Chris Lindsay, Evan Siegel, Phillip J Mease
Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of rheumatology (2022)
Robin Waxman, Carmel Stober, Deepak R Jadon, Ana Maria Orbai, Vinod Chandran, Philip S Helliwell, Stephen R Pennington, Maarten de Wit, Denis O'Sullivan, Phillip J Mease, April W Armstrong, Kristina Callis Duffin, Philip S Helliwell, Leonieke J J van Mens, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting. The Journal of rheumatology. Supplement 96 (2021)
Phillip J Mease, Leonard H Calabrese, Kristina Callis Duffin, Rebecca H Haberman, Rodrigo Firmino, Jose U Scher, Lori Schick, Kevin L Winthrop, Joseph Frank Merola
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology. Supplement 97 (2021)
Kristina Callis Duffin, Herve Bachelez, Phillip J Mease, Cheryl F Rosen, Amit Garg, Eric Zudak, Ori Elkayam, Joseph Frank Merola, Jeffrey Chau, Kishimoto Mitsumasa, Victoria Furer, Philip S Helliwell
Pustular Psoriasis and Associated Musculoskeletal Disorders. The Journal of rheumatology (2021)
Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Phillip J Mease, Philip S Helliwell, Denis O'Sullivan, Stephen R Pennington, Thorvardur Jon Love, Alberto Cauli, Leonieke J J van Mens, Robin Waxman, Jose U Scher, Richard B Warren, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of rheumatology (2021)
Marina N Magrey, Phillip J Mease
Pain in Axial Spondyloarthritis: More to It Than Just Inflammation. The Journal of rheumatology 48 (11) (2021)
Alexis Ogdie, Kurt de Vlam, Iain B McInnes, Phillip J Mease, Philip Baer, Tatjana Lukic, David Gruben, Kenneth Kwok, Cunshan Wang, Ming-Ann Hsu, Anna Maniccia
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. RMD open 6 (1) (2021)
Phillip J Mease, Robert B M Landewé, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Aimee Readie, Shephard Mpofu, Eumorphia Maria Delicha, Luminita Pricop, Désirée Mfm van der Heijde
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study. RMD open 7 (2) (2021)
Alexis Ogdie, Kaleb D Michaud, Miroslawa Nowak, Rachel Bruce, Sarah Cantor, Carlijn Hintzen, Phillip J Mease
Patient's experience of psoriatic arthritis: a conceptual model based on qualitative interviews. RMD open 6 (3) (2021)
Phillip J Mease, Filip E Van den Bosch
IL-23 and axial disease: do they come together? Rheumatology (Oxford, England) 60 (Suppl 4) (2021)
Lourdes Maria Perez-Chada, Alison H Kohn, Alice B Gottlieb, April W Armstrong, Lihi Eder, Phillip J Mease, Philip S Helliwell, Vibeke Strand, Joseph Frank Merola
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology. Supplement 97 (2021)
Phillip J Mease, Mohit Kumar Bhutani, Steven Hass, Esther Yi, Peter Hur, Nina Kim
Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review. Rheumatology and therapy 9 (2) (2021)
Phillip J Mease, Scott Stryker, Mei Liu, Bob Salim, Sabrina Rebello, Mahdi Gharaibeh, David H Collier
Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry. Arthritis research & therapy 23 (1) (2021)
Phillip J Mease, Leonard H Calabrese, Kristina Callis Duffin, Rebecca H Haberman, Rodrigo Firmino, Jose U Scher, Lori Schick, Kevin L Winthrop, Joseph Frank Merola
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology (2021)
Lourdes Maria Perez-Chada, Alison H Kohn, Alice B Gottlieb, April W Armstrong, Lihi Eder, Phillip J Mease, Philip S Helliwell, Vibeke Strand, Joseph Frank Merola
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. The Journal of rheumatology (2021)
Vibeke Strand, Phillip J Mease, Ervant J Maksabedian Hernandez, Bradley S Stolshek, Lyrica X H Liu, David H Collier, Gregory Kricorian, Joseph F Merola
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination. RMD open 7 (1) (2021)
Ying Ying Leung, Ana Maria Orbai, William Tillett, Philip S Helliwell, Lihi Eder, Niti Goel, Pil Højgaard, Richard Holland, Ashish J Mathew, Christine A Lindsay, Anna S Antony, Jeffrey Chau, Robin Christensen, Laura C Coates, Phillip J Mease, Vibeke Strand, Oliver M FitzGerald, Maarten P T de Wit, Kristina Callis Duffin, Dafna D Gladman
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of rheumatology (2021)
Lourdes M Perez-Chada, Rebecca H Haberman, Vinod Chandran, Cheryl F Rosen, Christopher Ritchlin, Lihi Eder, Phillip J Mease, Soumya Reddy, Alexis Ogdie, Joseph F Merola, Jose U Scher
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study. Nature reviews. Rheumatology 17 (4) (2021)
Kurt de Vlam, Alexis Ogdie, Andrew G Bushmakin, Joseph C Cappelleri, Roy M Fleischmann, Peter C Taylor, Valderilio Azevedo, Lara Fallon, John Woolcott, Phillip J Mease
Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib. RMD open 7 (2) (2021)
Phillip J Mease
New treatments for PsA meet targeted therapy goals. Nature reviews. Rheumatology 17 (2) (2021)
Morten B Pedersen, Peter Thinggaard, Rinie Geenen, Marianne U Rasmussen, Maarten De Wit, Lyn March, Phillip J Mease, Ernest H S Choy, Philip Gerard Conaghan, Lee Simon, Anne Faber Hansen, Simon Tarp, Berit Schiøttz-Christensen, Carsten B Juhl, Sabrina M Nielsen, Kirstine Amris, Robin Christensen
Biopsychosocial rehabilitation for inflammatory arthritis and osteoarthritis: A systematic review and meta-analysis of randomized trials. Arthritis care & research (2021)
Dennis G McGonagle, Iain B McInnes, Atul Deodhar, Georg Schett, May Shawi, Shelly Kafka, Chetan S Karyekar, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Christopher T Ritchlin, Proton Rahman, Phillip J Mease
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies. Rheumatology (Oxford, England) 60 (11) (2021)
Phillip J Mease, Saima Chohan, Ferran J Garcia Fructuoso, Michael E Luggen, Proton Rahman, Siba P Raychaudhuri, Richard C Chou, Alan M Mendelsohn, Stephen J Rozzo, Alice Gottlieb
Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study. Annals of the rheumatic diseases 80 (9) (2021)
Phillip J Mease, Dafna D Gladman, Arthur Kavanaugh, Dennis McGonagle, Peter Nash, Benoit Guerette, Priscila Nakasato, Michele Brunori, Lichen Teng, Iain B McInnes
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials. Rheumatology and therapy 8 (4) (2021)
Phillip J Mease, Amit Garg, Philip S Helliwell, null null
GRAPPA 2020 Update From the Education Committee. The Journal of rheumatology (2021)
Phillip J Mease, Iain B McInnes, Lai Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D Chakravarty, Anna Parackal, Chetan S Karyekar, Sandhya Nair, Wolf-Henning Boehncke, Christopher Ritchlin
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis. Rheumatology (Oxford, England) 60 (5) (2021)
Laura C Coates, Joseph Frank Merola, Suzanne M Dolwick Grieb, Phillip J Mease, Kristina Callis Duffin
Methotrexate in Psoriasis and Psoriatic Arthritis. The Journal of rheumatology. Supplement 96 (2021)
Niti Goel, Laura C Coates, Gabriele de Marco, Lihi Eder, Oliver M FitzGerald, Philip S Helliwell, Ying Ying Leung, Walter P Maksymowych, Phillip J Mease, Mikkel Østergaard, Denis O'Sullivan, Denis Poddubnyy, Christopher T Ritchlin, Dafna D Gladman
GRAPPA 2019 Project Report. The Journal of rheumatology. Supplement 96 (2021)
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Phillip J Mease, Uta Kiltz, Maxime Dougados, Robert B M Landewé, Désirée Mfm van der Heijde
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. The Journal of rheumatology 48 (12) (2021)
Ying Ying Leung, Ana Maria Orbai, William Tillett, Philip S Helliwell, Lihi Eder, Niti Goel, Pil Højgaard, Richard Holland, Ashish J Mathew, Christine A Lindsay, Anna S Antony, Jeffrey Chau, Robin Christensen, Laura C Coates, Phillip J Mease, Vibeke Strand, Oliver M FitzGerald, Maarten P T de Wit, Kristina Callis Duffin, Dafna D Gladman
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of rheumatology. Supplement 97 (2021)
Phillip J Mease, Robert R McLean, Blessing Dube, Mei Liu, Sabrina Rebello, Meghan Glynn, Esther Yi, Yujin Park, Alexis Ogdie
Dr. Mease et al reply. The Journal of rheumatology 48 (12) (2021)
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Désirée van der Heijde, Phillip J Mease
Long-term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through 2 Years: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naïve Patients with Active Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Kristina Callis Duffin, Herve Bachelez, Phillip J Mease, Cheryl F Rosen, Amit Garg, Eric Zudak, Ori Elkayam, Joseph Frank Merola, Jeffrey Chau, Kishimoto Mitsumasa, Victoria Furer, Philip S Helliwell
Pustular Psoriasis and Associated Musculoskeletal Disorders. The Journal of rheumatology. Supplement 97 (2021)
Oliver M FitzGerald, Alexis Ogdie, Vinod Chandran, Laura C Coates, Arthur Kavanaugh, William Tillett, Ying Ying Leung, Maarten P T de Wit, Jose U Scher, Phillip J Mease
Psoriatic arthritis. Nature reviews. Disease primers 7 (1) (2021)
Proton Rahman, Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Phillip J Mease, Alice B Gottlieb, Shelly Kafka, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang, Iain B McInnes
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis. The Journal of rheumatology 48 (12) (2021)
Dafna D Gladman, Philip S Helliwell, Denis Poddubnyy, Phillip J Mease
Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting. The Journal of rheumatology (2021)
Marie Skougaard, Tanja S Jørgensen, Mia J Jensen, Christine Ballegaard, Jørgen Guldberg-Møller, Alexander Egeberg, Robin Christensen, Peter Benzin, Zara R Stisen, Joseph F Merola, Laura C Coates, Vibeke Strand, Phillip J Mease, Lars Erik Kristensen
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study. Rheumatology advances in practice 5 (3) (2021)
Ying Ying Leung, William Tillett, Ana Maria Orbai, Philip S Helliwell, Lihi Eder, Laura C Coates, Richard Holland, Anna S Antony, Niti Goel, Phillip J Mease, Vibeke Strand, Oliver M FitzGerald, Maarten de Wit, Christine A Lindsay, Kristina Callis Duffin, Dafna D Gladman
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. The Journal of rheumatology. Supplement 96 (2021)
Phillip J Mease, Dafna D Gladman, Atul Deodhar, Dennis G McGonagle, Peter Nash, Wolf-Henning Boehncke, Alice Gottlieb, Xie L Xu, Stephen Xu, Elizabeth C Hsia, Chetan S Karyekar, Philip S Helliwell
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study. RMD open 6 (2) (2021)
Phillip J Mease, Amit Garg, Philip S Helliwell, null null
GRAPPA 2020 Update From the Education Committee. The Journal of rheumatology. Supplement 97 (2021)
Dafna D Gladman, Philip S Helliwell, Denis Poddubnyy, Phillip J Mease
Updates on Axial Psoriatic Arthritis From the 2020 GRAPPA Annual Meeting. The Journal of rheumatology. Supplement 97 (2021)
Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Phillip J Mease, Philip S Helliwell, Denis O'Sullivan, Stephen R Pennington, Thorvardur Jon Love, Alberto Cauli, Leonieke J J van Mens, Robin Waxman, Jose U Scher, Richard B Warren, Christopher T Ritchlin, Oliver M FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. The Journal of rheumatology. Supplement 97 (2021)
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng, Yusang Jiang, Bei Zhou, Yanli Zhuang, Désirée van der Heijde, Phillip J Mease
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 73 (4) (2021)
William Tillett, Neil J McHugh, Ana Maria Orbai, Philip S Helliwell, Ying Ying Leung, Laura C Coates, Phillip J Mease, Dafna D Gladman, Mel Brooke, Jon Packham, Denis O'Sullivan, Oliver M FitzGerald, Philip S Helliwell
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps. The Journal of rheumatology. Supplement 96 (2021)
Phillip J Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, Kyle Raymond, Iain McInnes
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials. Annals of the rheumatic diseases 80 (2) (2020)

Phillip J Mease.css-eqlu8i{font-size:small;padding-left:4px;} (Philip Mease, Phillip Mease, Philip J Mease)

Publication Activity (10 Years)

Top Topics

Top Venues

Phillip J Mease (Philip Mease, Phillip Mease, Philip J Mease)